COOK CHILDRENS MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $11.5M
- Transactions
- 2,632
- Companies
- 40
- Average per transaction
- $4,367
Who reported the payments
| Novartis | $2,726,086 |
| Amgen | $2,049,255 |
| Vertex | $1,039,283 |
| AbbVie | $594,212 |
| Jazz Pharmaceuticals Inc. | $528,534 |
| GW Research Limited | $459,726 |
| Zealand Pharma A/s | $378,037 |
| Eli Lilly | $331,209 |
| Pfizer | $208,669 |
| Regeneron | $191,122 |
| E.r. Squibb & Sons, L.L.C. | $182,255 |
| Gilead | $179,101 |
| Kls-martin L.p. | $174,692 |
| Janssen Research & Development, LLC | $159,067 |
| Ascendis Pharma Endocrinology Inc | $156,737 |
| Takeda Pharmaceuticals U.S.A., Inc. | $154,542 |
| AstraZeneca | $151,785 |
| Tesaro, Inc. | $141,056 |
| Merck | $140,430 |
| Bio-rad Laboratories, Inc. | $132,445 |
| Novo Nordisk AS | $115,588 |
| Diasorin Molecular LLC | $113,775 |
| Ultragenyx Pharmaceutical Inc. | $87,700 |
| Shionogi Inc | $76,675 |
| Dompe Farmaceutici S.p.a. | $71,467 |
| Zogenix Inc. | $70,044 |
| Olympus America Inc. | $67,698 |
| United Therapeutics Corporation | $63,487 |
| Linde Gas & Equipment Inc. | $63,184 |
| Genentech, Inc. | $53,801 |
| Med-el Corporation | $53,715 |
| National Marrow Donor Program | $50,085 |
| OPKO Pharmaceuticals, LLC | $44,987 |
| PTC Therapeutics, Inc. | $43,845 |
| Bayer | $42,087 |
| F. Hoffmann-la Roche AG | $40,326 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | $36,369 |
| Aurinia Pharma U.S., Inc. | $33,180 |
| CSL Behring | $32,100 |
| Global Blood Therapeutics, Inc. | $28,479 |